Healthy Extracts Inc (HYEX)

[sjoseph]

On October 17, 2017, Grey Cloak Tech Inc. (the “ Company ” also referred to herein as “ us ,” “ we ” and “ our ”), entered into a Share Exchange Agreement by and among the Company, Eqova Life Sciences, a Nevada corporation, Patrick Stiles, and Patrick Stiles in his capacity as the Selling Members’ Representative, whereby we issued and exchanged 1,100,000 shares of our Series A Convertible Preferred Stock for all of the outstanding securities of Eqova Life Sciences. Through this exchange of securities pursuant to the Exchange Agreement (the “ Exchange ”), Eqova Life Sciences is now our wholly-owned subsidiary. The shares of Series A Convertible Preferred Stock issued in this transaction are convertible into an aggregate number of shares that would equal 66% of our outstanding common stock after conversion. Each Share of our Series A Convertible Preferred Stock is convertible into 0.00006% of our outstanding common stock as of the date of conversion.